Literature DB >> 31745330

Antibiotic development - economic, regulatory and societal challenges.

Christine Årdal1, Manica Balasegaram2, Ramanan Laxminarayan3, David McAdams4, Kevin Outterson5, John H Rex6, Nithima Sumpradit7.   

Abstract

Mesh：

Substances：

Year:  2019        PMID： 31745330     DOI： 10.1038/s41579-019-0293-3

Source DB:  PubMed          Journal:  Nat Rev Microbiol        ISSN： 1740-1526            Impact factor:   60.633


× No keyword cloud information.
  1 in total

1.  Smallest biopharma firms are pushing more of the pipeline.

Authors:  Asher Mullard
Journal:  Nat Rev Drug Discov       Date:  2019-06       Impact factor: 84.694
  1 in total
  50 in total

1.  Market concentration of new antibiotic sales.

Authors:  Sakib Rahman; Olof Lindahl; Chantal M Morel; Aidan Hollis
Journal:  J Antibiot (Tokyo)       Date:  2021-03-04       Impact factor: 2.649

2.  New drugs for the antibacterial pipeline?

Authors:  Ashley York
Journal:  Nat Rev Microbiol       Date:  2020-02       Impact factor: 60.633

3.  Genotyping of paired KPC-producing Klebsiella pneumoniae isolates with and without divergent polymyxin B susceptibility profiles.

Authors:  Suely Carlos Ferreira Sampaio; Rozane de Lima Bigelli Carvalho; Marcelo Jenné Mimica; Cely Barreto da Silva; Lycia Mara Jenné Mimica; Aline Valerio de Lima; Keila de Oliveira Lima; Darlan Augusto da Costa Rocha; Jorge Luiz Mello Sampaio
Journal:  Braz J Microbiol       Date:  2021-08-30       Impact factor: 2.214

Review 4.  Ethnobotany and the Role of Plant Natural Products in Antibiotic Drug Discovery.

Authors:  Gina Porras; François Chassagne; James T Lyles; Lewis Marquez; Micah Dettweiler; Akram M Salam; Tharanga Samarakoon; Sarah Shabih; Darya Raschid Farrokhi; Cassandra L Quave
Journal:  Chem Rev       Date:  2020-11-09       Impact factor: 60.622

5.  Leveraging Marine Natural Products as a Platform to Tackle Bacterial Resistance and Persistence.

Authors:  M Alejandro Valdes-Pena; Nicholas P Massaro; You-Chen Lin; Joshua G Pierce
Journal:  Acc Chem Res       Date:  2021-03-18       Impact factor: 22.384

Review 6.  Rational approaches towards inorganic and organometallic antibacterials.

Authors:  Jeannine Hess
Journal:  Biol Chem       Date:  2021-07-13       Impact factor: 4.700

Review 7.  Multifaceted MRGPRX2: New insight into the role of mast cells in health and disease.

Authors:  Saptarshi Roy; Chalatip Chompunud Na Ayudhya; Monica Thapaliya; Vishwa Deepak; Hydar Ali
Journal:  J Allergy Clin Immunol       Date:  2021-05-04       Impact factor: 14.290

8.  Confidence interval methods for antimicrobial resistance surveillance data.

Authors:  Erta Kalanxhi; Gilbert Osena; Geetanjali Kapoor; Eili Klein
Journal:  Antimicrob Resist Infect Control       Date:  2021-06-09       Impact factor: 4.887

9.  Murepavadin, a Small Molecule Host Defense Peptide Mimetic, Activates Mast Cells via MRGPRX2 and MrgprB2.

Authors:  Aetas Amponnawarat; Chalatip Chompunud Na Ayudhya; Hydar Ali
Journal:  Front Immunol       Date:  2021-06-23       Impact factor: 7.561

10.  There is no market for new antibiotics: this allows an open approach to research and development.

Authors:  Dana M Klug; Fahima I M Idiris; Mark A T Blaskovich; Frank von Delft; Christopher G Dowson; Claas Kirchhelle; Adam P Roberts; Andrew C Singer; Matthew H Todd
Journal:  Wellcome Open Res       Date:  2021-06-11
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.